
Relogen Cancer Paramarsh Private Limited
About Relogen Cancer Paramarsh Private Limited
Data last updated:
Relogen Cancer Paramarsh Private Limited is a private limited company based in Varanasi, Uttar Pradesh, India. It was incorporated on 13 June 2024.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U86100UP2024PTC204578.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Archana Shahi and Uday Pratap Shahi.
Its last annual general meeting (AGM) was held on 20 November 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Varanasi, Uttar Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹2 Lakh. For the same year it recorded a net profit of ₹21,000 (net margin 10.5%) and EBITDA of ₹28,100 (EBITDA margin 14.1%).
Company details
Contact details
Relogen Cancer Paramarsh Private Limited's registered office is in Varanasi, Uttar Pradesh.
- Registered AddressC/O. Uday Pratap Shahi, Gautam Nagar Susuwahi, Varanasi, Uttar Pradesh, India – 221011
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Relogen Cancer Paramarsh Private Limited
FY 2025 filings availableRelogen Cancer Paramarsh Private Limited reported revenue of ₹2 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | ₹28,100 |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | ₹21,000 |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2024-25 |
|---|---|
| Profitability | |
| EBITDA Margin | 14.1% |
| Net Profit Margin | 10.5% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Relogen Cancer Paramarsh Private Limited, buy the company report.
Board of directors of Relogen Cancer Paramarsh Private Limited
Relogen Cancer Paramarsh has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Archana Shahi | Director | 13 Jun 2024 | 2 Years 5 Months | Current |
| Uday Pratap Shahi | Director | 13 Jun 2024 | 2 Years 5 Months | Current |
Legal cases
No court or tribunal cases involving Relogen Cancer Paramarsh Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Relogen Cancer Paramarsh Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Relogen Cancer Paramarsh Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Relogen Cancer Paramarsh Private Limited has 2 board changes on record since 2024: 2 appointments. The latest: Archana Shahi was appointed as Director on 13 Jun 2024.
Frequently asked questions
Relogen Cancer Paramarsh is an active private limited company based in Varanasi, Uttar Pradesh, India. It was incorporated on 13 June 2024 (2+ years old) and is registered under CIN U86100UP2024PTC204578.
Relogen Cancer Paramarsh has 2 current directors:
- Archana Shahi - Director
- Uday Pratap Shahi - Director
The latest financial statements of Relogen Cancer Paramarsh on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 20 November 2025. Year-wise statements from FY 2025 are in the company report.
The CIN (Corporate Identification Number) of Relogen Cancer Paramarsh is U86100UP2024PTC204578. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Relogen Cancer Paramarsh was incorporated on 13 June 2024, making it 2+ years old. It is registered with the Registrar of Companies, Kanpur.
Archana Shahi was appointed as Director on 13 Jun 2024. Uday Pratap Shahi was appointed as Director on 13 Jun 2024.
The registered office of Relogen Cancer Paramarsh is at CO. Uday Pratap Shahi, Gautam Nagar Susuwahi, Varanasi, Uttar Pradesh, India – 221011.
Relogen Cancer Paramarsh can be reached at its registered office: CO. Uday Pratap Shahi, Gautam Nagar Susuwahi, Varanasi, Uttar Pradesh, India – 221011.
Relogen Cancer Paramarsh is registered under the jurisdiction of the Registrar of Companies (ROC), Kanpur.

